期刊
CANCER CELL
卷 21, 期 3, 页码 283-296出版社
CELL PRESS
DOI: 10.1016/j.ccr.2012.03.003
关键词
-
资金
- Howard Hughes Medical Institute
- Cancer Prevention and Research Institute of Texas
- National Institute of Child Health and Human Development [K12 HD 068369-02]
The differentiation of tumorigenic cancer stem cells into nontumorigenic cancer cells confers heterogeneity to some cancers beyond that explained by clonal evolution or environmental differences. In such cancers, functional differences between tumorigenic and nontumorigenic cells influence response to therapy and prognosis. However, it remains uncertain whether the model applies to many, or few, cancers due to questions about the robustness of cancer stem cell markers and the extent to which existing assays underestimate the frequency of tumorigenic cells. In cancers with rapid genetic change, reversible changes in cell states, or biological variability among patients, the stem cell model may not be readily testable.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据